Clinical Adherence Program
Expanding Therapeutic Options For Your Diabetes Patients
Enhance patient care by offering additional therapeutic alternatives for Type 2 diabetes management.
Program Overview
The Wellgistics Hub Clinical Medication Adherence program enables participating pharmacies to provide patients with access to clinically appropriate SGLT-2 therapy, supporting improved medication adherence and patient outcomes.
Expanded Therapeutic Options
Provide your diabetes patients with additional medication choices
Clinical Flexibility
Greater flexibility in medication management for your patients
Comprehensive Clinical Support
Full support for medication adherence management
How This Program Works
Step 1: Pharmacy Enrollment
Contact Wellgistics Hub to enroll in the medication adherence program.
Step 2: Identify Patients
Find SGLT-2 patients who meet program criteria.
Step 3: Clinical Assessment
Discuss therapeutic options with patients and obtain prescriber authorization.
Step 4: Patient Enrollment
Enroll patients at: discountcard.wellgisticshub.com/brenzavvy
Use: BIN: 028413, PCN: WELL, Group: BRENZAV, ID: from discount Card
Step 5: Provide Clinical Services
Complete clinical documentation in the following steps, to receive $32 compensation per eligible patient.
Step 6: Billing in Pharmacy Management System
Print the completed form from the following pages and use as the Rx Image in your pharmacy management system.
Bill Wellgistics Hub for compensation using the following details:
Use: BIN: 028413, PCN: WELL, Group: BRENZAV, ID: from discount card, Adherence Program NDC: 28546-1225-00
Compensation
Receive fair market value for providing clinical services including:
- Clinical assessment and documentation
- Therapeutic history evaluation
- Patient education on medication safety
- Patient counseling
Patient Criteria
Include:
SGLT-2 patients (private insurance/self-pay) who meet program criteria
Exclude:
Medicare/Medicaid beneficiaries and other federal/state healthcare benefit recipients